When.com Web Search

  1. Ads

    related to: how to challenge patent reexamination in california

Search results

  1. Results From The WOW.Com Content Network
  2. Inter partes review - Wikipedia

    en.wikipedia.org/wiki/Inter_partes_review

    An inter partes review is used to challenge the patentability of one or more claims in a U.S. patent only on a ground that could be raised under 35 U.S.C. §§ 102 or 103 (non-obviousness), and only on the basis of prior art consisting of patents or printed publications. [3]

  3. Patent opposition proceedings - Wikipedia

    en.wikipedia.org/wiki/Patent_opposition_proceedings

    In addition to opposition proceedings, several other mechanisms enable third parties to influence the patent granting process or challenge patents: Third-party observations : Individuals or entities can submit observations on the patentability of an invention during the examination phase, providing relevant prior art or arguments without ...

  4. Reexamination - Wikipedia

    en.wikipedia.org/wiki/Reexamination

    A request for a reexamination can be filed by anyone at any time during the period of enforceability of a patent. To request a reexamination, one must submit a "request for reexamination" which includes (1) a statement pointing out each "substantial new question of patentability based on prior patents and printed publications; (2) an identification and explanation for every claim for which ...

  5. Opposition proceeding - Wikipedia

    en.wikipedia.org/wiki/Opposition_proceeding

    An opposition proceeding is an administrative process available under the patent and trademark law of many jurisdictions which allows third parties to formally challenge the validity of a pending patent application ("pre-grant opposition"), of a granted patent ("post-grant opposition"), or of a trademark.

  6. U.S. Supreme Court spurns Apple-Broadcom challenge to ... - AOL

    www.aol.com/news/u-supreme-court-spurns-apple...

    The U.S. Supreme Court on Monday declined to hear a bid by Apple Inc and Broadcom Inc to revive their challenges to Caltech data-transmission patents in a patent infringement case in which the ...

  7. US Patent Office won't review two Novo Nordisk patents for ...

    www.aol.com/news/us-patent-office-wont-review...

    A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought ...